Cargando…
Sex-specific metabolic functions of adipose Lipocalin-2
OBJECTIVE: Lipocalin-2 (LCN2) is a secreted protein involved in innate immunity and has also been associated with several cardiometabolic traits in both mouse and human studies. However, the causal relationship of LCN2 to these traits is unclear, and most studies have examined only males. METHODS: U...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812340/ https://www.ncbi.nlm.nih.gov/pubmed/31767179 http://dx.doi.org/10.1016/j.molmet.2019.09.009 |
_version_ | 1783462641128177664 |
---|---|
author | Chella Krishnan, Karthickeyan Sabir, Simon Shum, Michaël Meng, Yonghong Acín-Pérez, Rebeca Lang, Jennifer M. Floyd, Raquel R. Vergnes, Laurent Seldin, Marcus M. Fuqua, Brie K. Jayasekera, Dulshan W. Nand, Sereena K. Anum, Diana C. Pan, Calvin Stiles, Linsey Péterfy, Miklós Reue, Karen Liesa, Marc Lusis, Aldons J. |
author_facet | Chella Krishnan, Karthickeyan Sabir, Simon Shum, Michaël Meng, Yonghong Acín-Pérez, Rebeca Lang, Jennifer M. Floyd, Raquel R. Vergnes, Laurent Seldin, Marcus M. Fuqua, Brie K. Jayasekera, Dulshan W. Nand, Sereena K. Anum, Diana C. Pan, Calvin Stiles, Linsey Péterfy, Miklós Reue, Karen Liesa, Marc Lusis, Aldons J. |
author_sort | Chella Krishnan, Karthickeyan |
collection | PubMed |
description | OBJECTIVE: Lipocalin-2 (LCN2) is a secreted protein involved in innate immunity and has also been associated with several cardiometabolic traits in both mouse and human studies. However, the causal relationship of LCN2 to these traits is unclear, and most studies have examined only males. METHODS: Using adeno-associated viral vectors we expressed LCN2 in either adipose or liver in a tissue specific manner on the background of a whole-body Lcn2 knockout or wildtype mice. Metabolic phenotypes including body weight, body composition, plasma and liver lipids, glucose homeostasis, insulin resistance, mitochondrial phenotyping, and metabolic cage studies were monitored. RESULTS: We studied the genetics of LCN2 expression and associated clinical traits in both males and females in a panel of 100 inbred strains of mice (HMDP). The natural variation in Lcn2 expression across the HMDP exhibits high heritability, and genetic mapping suggests that it is regulated in part by Lipin1 gene variation. The correlation analyses revealed striking tissue dependent sex differences in obesity, insulin resistance, hepatic steatosis, and dyslipidemia. To understand the causal relationships, we examined the effects of expression of LCN2 selectively in liver or adipose. On a Lcn2-null background, LCN2 expression in white adipose promoted metabolic disturbances in females but not males. It acted in an autocrine/paracrine manner, resulting in mitochondrial dysfunction and an upregulation of inflammatory and fibrotic genes. On the other hand, on a null background, expression of LCN2 in liver had no discernible impact on the traits examined despite increasing the levels of circulating LCN2 more than adipose LCN2 expression. The mechanisms underlying the sex-specific action of LCN2 are unclear, but our results indicate that adipose LCN2 negatively regulates its receptor, LRP2 (or megalin), and its repressor, ERα, in a female-specific manner and that the effects of LCN2 on metabolic traits are mediated in part by LRP2. CONCLUSIONS: Following up on our population-based studies, we demonstrate that LCN2 acts in a highly sex- and tissue-specific manner in mice. Our results have important implications for human studies, emphasizing the importance of sex and the tissue source of LCN2. |
format | Online Article Text |
id | pubmed-6812340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-68123402019-10-30 Sex-specific metabolic functions of adipose Lipocalin-2 Chella Krishnan, Karthickeyan Sabir, Simon Shum, Michaël Meng, Yonghong Acín-Pérez, Rebeca Lang, Jennifer M. Floyd, Raquel R. Vergnes, Laurent Seldin, Marcus M. Fuqua, Brie K. Jayasekera, Dulshan W. Nand, Sereena K. Anum, Diana C. Pan, Calvin Stiles, Linsey Péterfy, Miklós Reue, Karen Liesa, Marc Lusis, Aldons J. Mol Metab Original Article OBJECTIVE: Lipocalin-2 (LCN2) is a secreted protein involved in innate immunity and has also been associated with several cardiometabolic traits in both mouse and human studies. However, the causal relationship of LCN2 to these traits is unclear, and most studies have examined only males. METHODS: Using adeno-associated viral vectors we expressed LCN2 in either adipose or liver in a tissue specific manner on the background of a whole-body Lcn2 knockout or wildtype mice. Metabolic phenotypes including body weight, body composition, plasma and liver lipids, glucose homeostasis, insulin resistance, mitochondrial phenotyping, and metabolic cage studies were monitored. RESULTS: We studied the genetics of LCN2 expression and associated clinical traits in both males and females in a panel of 100 inbred strains of mice (HMDP). The natural variation in Lcn2 expression across the HMDP exhibits high heritability, and genetic mapping suggests that it is regulated in part by Lipin1 gene variation. The correlation analyses revealed striking tissue dependent sex differences in obesity, insulin resistance, hepatic steatosis, and dyslipidemia. To understand the causal relationships, we examined the effects of expression of LCN2 selectively in liver or adipose. On a Lcn2-null background, LCN2 expression in white adipose promoted metabolic disturbances in females but not males. It acted in an autocrine/paracrine manner, resulting in mitochondrial dysfunction and an upregulation of inflammatory and fibrotic genes. On the other hand, on a null background, expression of LCN2 in liver had no discernible impact on the traits examined despite increasing the levels of circulating LCN2 more than adipose LCN2 expression. The mechanisms underlying the sex-specific action of LCN2 are unclear, but our results indicate that adipose LCN2 negatively regulates its receptor, LRP2 (or megalin), and its repressor, ERα, in a female-specific manner and that the effects of LCN2 on metabolic traits are mediated in part by LRP2. CONCLUSIONS: Following up on our population-based studies, we demonstrate that LCN2 acts in a highly sex- and tissue-specific manner in mice. Our results have important implications for human studies, emphasizing the importance of sex and the tissue source of LCN2. Elsevier 2019-09-27 /pmc/articles/PMC6812340/ /pubmed/31767179 http://dx.doi.org/10.1016/j.molmet.2019.09.009 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Chella Krishnan, Karthickeyan Sabir, Simon Shum, Michaël Meng, Yonghong Acín-Pérez, Rebeca Lang, Jennifer M. Floyd, Raquel R. Vergnes, Laurent Seldin, Marcus M. Fuqua, Brie K. Jayasekera, Dulshan W. Nand, Sereena K. Anum, Diana C. Pan, Calvin Stiles, Linsey Péterfy, Miklós Reue, Karen Liesa, Marc Lusis, Aldons J. Sex-specific metabolic functions of adipose Lipocalin-2 |
title | Sex-specific metabolic functions of adipose Lipocalin-2 |
title_full | Sex-specific metabolic functions of adipose Lipocalin-2 |
title_fullStr | Sex-specific metabolic functions of adipose Lipocalin-2 |
title_full_unstemmed | Sex-specific metabolic functions of adipose Lipocalin-2 |
title_short | Sex-specific metabolic functions of adipose Lipocalin-2 |
title_sort | sex-specific metabolic functions of adipose lipocalin-2 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812340/ https://www.ncbi.nlm.nih.gov/pubmed/31767179 http://dx.doi.org/10.1016/j.molmet.2019.09.009 |
work_keys_str_mv | AT chellakrishnankarthickeyan sexspecificmetabolicfunctionsofadiposelipocalin2 AT sabirsimon sexspecificmetabolicfunctionsofadiposelipocalin2 AT shummichael sexspecificmetabolicfunctionsofadiposelipocalin2 AT mengyonghong sexspecificmetabolicfunctionsofadiposelipocalin2 AT acinperezrebeca sexspecificmetabolicfunctionsofadiposelipocalin2 AT langjenniferm sexspecificmetabolicfunctionsofadiposelipocalin2 AT floydraquelr sexspecificmetabolicfunctionsofadiposelipocalin2 AT vergneslaurent sexspecificmetabolicfunctionsofadiposelipocalin2 AT seldinmarcusm sexspecificmetabolicfunctionsofadiposelipocalin2 AT fuquabriek sexspecificmetabolicfunctionsofadiposelipocalin2 AT jayasekeradulshanw sexspecificmetabolicfunctionsofadiposelipocalin2 AT nandsereenak sexspecificmetabolicfunctionsofadiposelipocalin2 AT anumdianac sexspecificmetabolicfunctionsofadiposelipocalin2 AT pancalvin sexspecificmetabolicfunctionsofadiposelipocalin2 AT stileslinsey sexspecificmetabolicfunctionsofadiposelipocalin2 AT peterfymiklos sexspecificmetabolicfunctionsofadiposelipocalin2 AT reuekaren sexspecificmetabolicfunctionsofadiposelipocalin2 AT liesamarc sexspecificmetabolicfunctionsofadiposelipocalin2 AT lusisaldonsj sexspecificmetabolicfunctionsofadiposelipocalin2 |